Rockefeller Capital Management
LEGN icon

Rockefeller Capital Management’s Legend Biotech LEGN Stock Holding History

Rockefeller Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.89M Buy
134,864
+51,686
+62% +$1.39M 0.01% 1089
2026
Q1 		$1.5M Buy
83,178
+83,122
+148,432% +$1.58M ﹤0.01% 1423
2025
Q4 		$1.23K Buy
56
+37
+195% +$1.06K ﹤0.01% 4418
2025
Q3 		$620 Buy
+19
New +$702 ﹤0.01% 4244
2022
Q1 		– Sell
-1,000
Closed -$46K – 3982
2021
Q4 		$46K Sell
1,000
-500
-33% -$25.4K ﹤0.01% 2258
2021
Q3 		$75K Buy
+1,500
New +$62.4K ﹤0.01% 1984

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Rockefeller Capital Management's LEGN Position: Q2 2026 in Review

Rockefeller Capital Management increased its Legend Biotech (LEGN) stake by 62% in Q2 2026, buying an estimated $1.39M and bringing the position to 134,864 shares worth $3.89M. The position accounts for 0.01% of the portfolio, ranked #1089.

Rockefeller Capital Management first reported a position in LEGN in Q3 2021 and has held it in 6 quarters since. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Rockefeller Capital Management held 134,864 shares of Legend Biotech worth $3.89M as of Q2 2026.
  • Rockefeller Capital Management bought 51,686 Legend Biotech shares in Q2 2026, an estimated $1.39M.
  • Legend Biotech made up 0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #1089 holding.
  • Rockefeller Capital Management first reported a position in Legend Biotech in Q3 2021 and has held it in 6 quarters since.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.